Cytek Biosciences, Inc. 8-K

What Happened

• Cytek Biosciences, Inc. (CTKB) filed a Form 8-K on June 25, 2026 reporting that Valerie Barnett’s role as Chief Legal Officer and Corporate Secretary will terminate effective June 29, 2026. The company and Ms. Barnett agreed to the separation, which the filing says is not due to any disagreement with the company’s operations, policies or practices.

Key Details

• Officer: Valerie Barnett — Chief Legal Officer and Corporate Secretary.
• Effective date: June 29, 2026.
• Filing date / Form: Form 8-K filed June 25, 2026 under Item 5.02 (departure/election of directors or certain officers).
• Reason: Separation stated as not due to any disagreement with the Company’s operations, policies or practices; no successor or additional separation terms disclosed in the filing.

Why It Matters

• Executive departures affect company governance and compliance oversight; the Chief Legal Officer plays a key role in legal, regulatory and disclosure matters. Investors should note the change and watch for any announcement of a successor or additional filings that disclose transition arrangements. The filing indicates the departure is an agreed separation and not due to disagreement, which is typically viewed as less likely to signal internal conflict.